Trial intelligence / Profile preview

Lyophilized human rabies vaccine (Vero cell) different regimens in healthy 10–60-year-olds

CTR20190561Phase 3Completed

Sponsor
Guangzhou Nuocheng Bioproducts
Start
Mar 2019
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of Rabies vaccine in rabies, sponsored by Guangzhou Nuocheng Bioproducts. Started Mar 2019; status: completed.

02

Drugs

Rabies vaccine
03

Conditions

rabies

Beyond the preview

Go deeper on CTR20190561.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20190561.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call